4.1 Comprehensive Patient & Periwound Physical Examination

4.1 Comprehensive Patient & Periwound Physical Examination

Core Clinical Principle: Chronic wounds rarely exist in isolation; they represent cutaneous manifestations of profound systemic pathology. Comprehensive evaluation requires eliciting a high-yield history (glycemic control, cardiovascular disease, pack-years of tobacco use, renal disease, nutritional markers, and ambulatory biomechanics) combined with standardized, objective physical examination of the wound bed and periwound halo. Differentiating directional tunneling from peripheral undermining and utilizing validated scoring systems like the PUSH 3.0 tool are non-negotiable standards for physician-level wound management.

---

Systematic Clinical History & Comorbidity Review

For the Certified Wound Specialist Physician (CWSP), eliciting a structured, comprehensive history is the indispensable first step in establishing wound etiology, identifying modifiable healing barriers, and anticipating systemic complications.

1. Diabetes Mellitus & Glycemic Metrics

Diabetes impairs wound repair across every biological phase. Chronic hyperglycemia drives the non-enzymatic glycation of circulating proteins, producing Advanced Glycation End-Products (AGEs). Binding of AGEs to their cell-surface receptor (RAGE) on macrophages and endothelial cells triggers sustained NF-κB nuclear translocation, perpetuating a destructive, pro-inflammatory microenvironment characterized by uninhibited matrix metalloproteinases (MMPs) and degraded growth factors.

• Glycemic Control: Review recent glycated hemoglobin (HbA1c) and continuous glucose monitor (CGM) glycemic variability metrics. An HbA1c >8.0% (and particularly >10.0%) correlates with marked suppression of neutrophil oxidative burst, defective macrophage phagocytosis, impaired fibroblast proliferation, and blunted capillary neovascularization.
• End-Organ Microvascular & Neuropathic Burden: Actively document diabetic retinopathy, nephropathy (microalbuminuria, elevated creatinine), and peripheral neuropathy (distal symmetric polyneuropathy and autonomic denervation). The presence of end-organ microvascular complications directly parallels the severity of dermal capillary basement membrane thickening.

2. Cardiovascular Disease & Peripheral Perfusion

• Atherosclerotic Burden: Identify prior coronary artery disease (CAD), myocardial infarction, carotid stenosis, and peripheral artery disease (PAD) interventions (angioplasty, stenting, or bypass grafting).
• Heart Failure & Venous Stasis: Congestive heart failure (CHF) elevates central venous pressure, exacerbating lower extremity dependency edema, microvascular capillary hypertension, and pericapillary fibrin cuff deposition that impedes oxygen diffusion.

3. Tobacco Smoking Exposure

Tobacco exposure must be quantified precisely in pack-years (packs smoked per day multiplied by years of smoking).

• Nicotine Vasoconstriction: Inhaled nicotine stimulates sympathetic ganglia and adrenal release of catecholamines, producing potent cutaneous alpha-1 adrenergic vasoconstriction that reduces dermal blood flow by up to 40% for several hours post-consumption.
• Carbon Monoxide Toxicity: Hemoglobin binds carbon monoxide with an affinity approximately 200 to 250 times greater than oxygen, forming carboxyhemoglobin, reducing oxygen-carrying capacity, and shifting the oxyhemoglobin dissociation curve to the left so that tissues unload oxygen less readily.
• Hydrogen Cyanide: Inhibits cytochrome c oxidase in the mitochondrial electron transport chain, arresting cellular ATP generation necessary for cellular proliferation, protein synthesis, and active membrane transport.

4. End-Stage Renal Disease (ESRD) & Uremic Milieu

Patients on maintenance hemodialysis or peritoneal dialysis experience delayed healing secondary to uremic platelet dysfunction, chronic systemic inflammation, anemia of chronic disease, and severe mineral and bone disorder (MBD). Hyperphosphatemia and an elevated calcium-phosphate ion product ($Ca \times P > 55\text{ mg}^2/\text{dL}^2$) accelerate Mönckeberg medial arterial calcification and place the patient at high risk for calciphylaxis (calcific uremic arteriolopathy).

5. Autoimmune & Connective Tissue Diseases

Inquire specifically about rheumatoid arthritis, systemic lupus erythematosus (SLE), systemic sclerosis (scleroderma), antiphospholipid syndrome, and inflammatory bowel disease. These etiologies frequently present with atypical cutaneous ulcerations driven by leukocytoclastic vasculitis, microthrombosis, or neutrophilic dermatoses (e.g., pyoderma gangrenosum), which exhibit pathergy and deteriorate precipitously if subjected to sharp surgical debridement.

6. Nutrition History & Laboratory Context

Screen every wound patient for malnutrition risk (recent weight loss, reduced intake, functional decline) and refer for a registered dietitian assessment when screening is positive. Section 5.4 covers formal nutrition assessment.

7. Ambulatory Status & Biomechanical Assessment

Evaluate ambulatory status (non-weight-bearing, partial weight-bearing, full unassisted ambulation), assistive device utilization (crutches, walker, wheelchair), and shoe-gear wear patterns. Complete a targeted biomechanical foot examination to identify structural deformities: hallux rigidus, hammer/claw toes, prominent metatarsal heads, equinus contracture of the gastrocnemius-soleus complex, and midfoot collapse characteristic of Charcot neuroarthropathy (rocker-bottom deformity). Areas of elevated focal peak plantar pressure correlate directly with neuropathic ulcer recurrence.

---

Physical Examination of the Wound Bed

Standardized Anatomical Localization

Accurate documentation requires anatomical specificity referencing standard bony landmarks and anatomical planes (e.g., "right plantar foot overlying the 1st metatarsophalangeal joint" or "left medial malleolus 2 cm superior to the distal tip"), avoiding ambiguous terms such as "ankle" or "lower leg."

Wound Measurement Modalities

Serial objective measurement is mandatory to quantify healing trajectory. Early percentage area reduction predicts closure: in diabetic foot ulcers, a reduction of about 50% at 4 weeks (Sheehan et al., 2003) predicts healing by 12 weeks, and in venous leg ulcers a reduction of roughly 40% at 3–4 weeks is predictive.

                    12:00 (Cephalad / Toward Head)
                                 ^
                                 |
                                 |
             [ Undermining: 1:00 to 4:00 (2.5 cm) ]
                                 |
      9:00 <---------------------+---------------------> 3:00
      (Right)                    |                      (Left)
                                 |
                                 |      [ Tunneling at 7:00 (4.0 cm) ]
                                 v       /
                     6:00 (Caudad / Toward Feet)

1. Linear Metric Ruler (Clock Method):
   • Length: Longest head-to-toe dimension along the 12:00-to-6:00 axis.
   • Width: Widest lateral dimension perpendicular to the length axis (9:00 to 3:00 axis).
   • Depth: Maximum vertical distance from the plane of the intact periwound skin to the deepest visible point of the wound base, measured using a sterile, flexible cotton-tipped or graduated probe.
   • Limitation: Overestimates irregular wound surface area by 10% to 40% compared to true geometric surface area.
2. Kundin Three-Dimensional Gauge:
   • Utilizes a specialized plastic caliper that measures length, width, and depth to calculate volume using the validated Kundin mathematical formula: $\text{Volume} = \text{Length} \times \text{Width} \times \text{Depth} \times 0.327$
   • The constant 0.327 accounts for the three-dimensional semi-ellipsoidal/parabolic geometry of biological wounds (derived from the two-dimensional elliptical area constant $\frac{\pi}{4} \approx 0.785$ multiplied by a depth/tapering geometry factor of $\approx 0.416$).
3. Digital Planimetry (Two-Dimensional):
   • Involves non-contact calibrated digital photography. A calibrated target (e.g., metric adhesive sticker) is placed adjacent to the wound. Digital tracing software calculates precise surface area ($cm^2$) and perimeter ($cm$) by counting image pixels, significantly reducing inter-rater variability.
4. Stereophotogrammetry & Optical 3D Surface Scanning:
   • Employs multi-lens cameras, structured light, or laser triangulation to render a high-density three-dimensional mesh of the wound.
   • Directly computes surface area, maximum depth, mean depth, and true cavity volume ($cm^3$) without patient contact, yielding an inter-observer coefficient of variation <5%.

Tunneling, Undermining & Sinus Tracts: Anatomical Distinctions

Proper documentation requires standard clock-face referencing where 12:00 points cephalad (toward the patient's head) and 6:00 points caudad (toward the feet), regardless of patient positioning.

• Tunneling: A narrow pathway of tissue destruction that proceeds in a single, specific directional trajectory from the wound margin into deeper subcutaneous tissue or along fascial planes. Documented by specifying the entry clock position and linear depth in centimeters (e.g., "tunneling noted at 7:00 extending 4.2 cm").
• Undermining: Tissue destruction extending beneath intact skin along the wound periphery, producing a shelf or lip of overhanging dermal/epidermal tissue. Occurs across a wide arc rather than a single channel. Documented by contiguous clock hours and depth (e.g., "undermining present from 1:00 to 4:00, measuring up to 2.5 cm at its deepest point"). Driven primarily by horizontal shear forces.
• Sinus Tract: An abnormal communication channel or dead-end pathway that extends from a deep focus of suppuration (such as an infected joint capsule, retained foreign body, or osteomyelitic bone) through fascial planes to the epithelial surface or wound base.

Wound Base Tissue Characterization

Document the exact percentage (summing to 100%) of each tissue phenotype across the wound base:

• Granulation Tissue: Highly vascularized, cellular connective tissue consisting of neo-capillary loops, active fibroblasts, and delicate provisional collagen matrix. Normal granulation is firm, granular, moist, and "beefy red." Hypergranulation (proud flesh) is light red or violaceous, friable, edematous tissue that grows above the surrounding epithelial margin; it inhibits keratinocyte migration and indicates prolonged inflammation, persistent micro-trauma, or excessive moisture/biofilm.
• Slough: Nonviable, devitalized tissue composed of dead leukocytes, fibrin, cellular debris, denatured collagen, and bacterial matrix. Appears stringy, mucinous, or adherent; color ranges from creamy white, yellow, tan, to pale green. Slough must be removed because it sustains bacterial proliferation and acts as a mechanical barrier to epithelial advancement.
• Eschar: Nonviable, necrotic tissue resulting from severe tissue hypoperfusion, full-thickness cellular death, and desiccation. Appears hard, dry, leathery, and black or dark brown. Dry, stable, non-infected eschar on an ischemic heel or unvascularized digit serves as a protective biological shield and must not be debrided until vascular reconstruction is accomplished.

Exudate Evaluation: Quantity & Quality

Exudate production reflects the permeability of the local capillary bed, osmotic gradient, and inflammatory status.

Exudate Qualities:

• Serous: Thin, watery, clear to light yellow; normal transudate during early proliferation.
• Serosanguineous: Thin, watery, pale pink to light red; reflects transudate with minor capillary extravasation.
• Sanguineous: Thin to slightly viscous, bright red; reflects fresh capillary hemorrhage (e.g., post-debridement or mechanical trauma).
• Purulent: Thick, viscous, opaque liquid ranging from creamy yellow to brown or green; contains degenerate neutrophils, cellular debris, and bacteria. Often accompanied by foul odor.
• Fibrinous: Thin, cloudy, viscous fluid rich in fibrin strands; common in chronic persistent inflammation.

Periwound Skin Assessment (The 4-cm Halo)

The periwound region (defined as the skin extending at least 4 cm beyond the wound margins) reveals critical pathophysiological data:

• Maceration: Waterlogged, softened, pale white skin resulting from excessive moisture and chronic exudate exposure. Macerated tissue contains high concentrations of destructive matrix metalloproteinases and neutrophil elastase that dissolve the periwound stratum corneum.
• Erythema: Capillary dilation producing localized redness. Differentiate cellulitis (erythema extending >2 cm from margin, asymmetrical, warm, indurated, tender, advancing borders) from dependent rubor (associated with severe arterial ischemia; foot turns bright red when dependent and blanches pale white when elevated >30 degrees) and venous stasis dermatitis (bilateral, brownish hemosiderin hyperpigmentation, pruritic, non-tender).
• Induration: Hardening of subcutaneous tissue detected by palpation; indicates deep inflammatory edema, abscess formation, or compartment hypertension.
• Callosity (Hyperkeratosis): Thickened stratum corneum formed in response to chronic, repetitive mechanical shear or pressure. In neuropathic feet, calluses act like rigid foreign bodies that concentrate plantar pressure (removing callus lowered peak pressure by about 29% in one study) and predispose to subkeratotic hematoma and cavitation. Must be pared sharply before wound staging.
• Xerosis & Anhidrosis: Marked dryness, scaling, and fissure formation resulting from sympathetic autonomic neuropathy with denervation of dermal eccrine and sebaceous glands.
• Denudation: Loss of the superficial epidermal layer resulting from prolonged chemical exposure (enzymatic wound exudate or fecal/urinary incontinence) or mechanical epidermal stripping from medical adhesives.

---

Validated Assessment Scoring Instruments

Standardized clinical scales convert qualitative observations into quantitative indices, enabling objective tracking of wound deterioration or regeneration across multi-provider care teams.

1. Bates-Jensen Wound Assessment Tool (BWAT)

The BWAT (formerly the Pressure Sore Status Tool [PSST]) evaluates 13 distinct wound characteristics, each scored on a modified Likert scale from 1 (optimal/healthy) to 5 (most degenerated/severe):

1. Size (Surface area calculation)
2. Depth
3. Edges (Indistinct, attached, non-attached, rolled/epibole, or hyperkeratotic)
4. Undermining / Tunneling (Extent around perimeter)
5. Necrotic Tissue Type (None, white/gray, yellow slough, black eschar)
6. Necrotic Tissue Amount (% of bed covered)
7. Exudate Type (None, bloody, serosanguineous, serous, purulent)
8. Exudate Amount (None, scant, small, moderate, large)
9. Skin Color Surrounding Wound (Pink, bright red, pale/white, purple/black)
10. Peripheral Tissue Edema (None to crepitus/massive edema)
11. Peripheral Tissue Induration (None to >4 cm around wound)
12. Granulation Tissue (Skin intact to <25% of bed covered with pale granulation)
13. Epithelialization (100% wound covered to <25% wound covered)

• Scoring Continuum: Total score ranges from 13 to 65. A score of 13 indicates a completely healed/regenerated wound. Progressively higher scores signify worsening tissue degeneration and bioburden.

2. Pressure Ulcer Scale for Healing (PUSH Tool version 3.0)

Developed by the National Pressure Ulcer Advisory Panel (NPIAP, formerly NPUAP), the PUSH 3.0 tool provides a rapid, validated instrument specifically sensitive to healing dynamics over weekly intervals.

$\text{Total PUSH Score (0 to 17)} = \text{Sub-score A (Area)} + \text{Sub-score B (Exudate)} + \text{Sub-score C (Tissue)}$

• Prognostic Utility: Total score ranges from 0 (completely healed) to 17 (worst healing status). By plotting scores weekly, clinicians establish whether a wound is on a normal regenerative trajectory (downward trending score) or failing to progress, signaling an unaddressed systemic, bioburden, or perfusion barrier.